# Cellanome

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cellanome

- Industry: Biotechnology
- Headquarters: Palo Alto, US
- Website: www.cellanome.com
- Total disclosed funding: $150M
- Latest round: Series B (Dec 4, 2023)
- Investors on record: 2

## About

Based in California, US, and founded in 2020, Cellanome, Inc. is a biotechnology company. In July 2022, Cellanome, Inc. raised USD 150 million in Series B funding from DCVC and 8VC. The company was founded by Mostafa Ronaghi. As of 2024, the company is led by its CEO, Omead Ostadan.

Cellanome develops and offers an automated platform to study individual cells through sequencing, microfluidics, computational biology, and molecular biology. The platform provides a deeper understanding of how individual cells behave, interact, and function under various stimuli and conditions. The company allows researchers to study the behavior, interactions, and functions of individual cells.

## Funding rounds

- Series B, Dec 4, 2023, $150M — DCVC, 8VC

## Investors

- DCVC (https://capitalatlas.ai/funds/dcvc) — Series B
- 8VC (https://capitalatlas.ai/funds/8vc) — Series B